PMC:7243768 / 34415-36272 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

LitCovid-PD-FMA-UBERON

LitCovid-PD-UBERON

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T150","span":{"begin":186,"end":192},"obj":"Body_part"},{"id":"T151","span":{"begin":261,"end":267},"obj":"Body_part"},{"id":"T152","span":{"begin":384,"end":389},"obj":"Body_part"},{"id":"T153","span":{"begin":546,"end":552},"obj":"Body_part"},{"id":"T154","span":{"begin":1061,"end":1066},"obj":"Body_part"},{"id":"T155","span":{"begin":1102,"end":1107},"obj":"Body_part"},{"id":"T156","span":{"begin":1189,"end":1194},"obj":"Body_part"},{"id":"T157","span":{"begin":1458,"end":1464},"obj":"Body_part"},{"id":"T158","span":{"begin":1525,"end":1530},"obj":"Body_part"},{"id":"T159","span":{"begin":1654,"end":1660},"obj":"Body_part"},{"id":"T160","span":{"begin":1793,"end":1799},"obj":"Body_part"},{"id":"T161","span":{"begin":1815,"end":1821},"obj":"Body_part"}],"attributes":[{"id":"A150","pred":"uberon_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A151","pred":"uberon_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A152","pred":"uberon_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A153","pred":"uberon_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A154","pred":"uberon_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A155","pred":"uberon_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A156","pred":"uberon_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A157","pred":"uberon_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A158","pred":"uberon_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A159","pred":"uberon_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A160","pred":"uberon_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A161","pred":"uberon_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"According to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

LitCovid-PD-MONDO

LitCovid-PD-CLO

LitCovid-PD-CHEBI

LitCovid-sentences

{"project":"LitCovid-sentences","denotations":[{"id":"T231","span":{"begin":0,"end":282},"obj":"Sentence"},{"id":"T232","span":{"begin":283,"end":488},"obj":"Sentence"},{"id":"T233","span":{"begin":489,"end":595},"obj":"Sentence"},{"id":"T234","span":{"begin":596,"end":806},"obj":"Sentence"},{"id":"T235","span":{"begin":807,"end":946},"obj":"Sentence"},{"id":"T236","span":{"begin":947,"end":1019},"obj":"Sentence"},{"id":"T237","span":{"begin":1020,"end":1130},"obj":"Sentence"},{"id":"T238","span":{"begin":1131,"end":1233},"obj":"Sentence"},{"id":"T239","span":{"begin":1234,"end":1322},"obj":"Sentence"},{"id":"T240","span":{"begin":1323,"end":1451},"obj":"Sentence"},{"id":"T241","span":{"begin":1452,"end":1547},"obj":"Sentence"},{"id":"T242","span":{"begin":1548,"end":1615},"obj":"Sentence"},{"id":"T243","span":{"begin":1616,"end":1857},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"According to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

LitCovid-PD-HP

{"project":"LitCovid-PD-HP","denotations":[{"id":"T172","span":{"begin":253,"end":275},"obj":"Phenotype"},{"id":"T173","span":{"begin":469,"end":480},"obj":"Phenotype"},{"id":"T174","span":{"begin":540,"end":559},"obj":"Phenotype"},{"id":"T175","span":{"begin":561,"end":564},"obj":"Phenotype"},{"id":"T176","span":{"begin":1452,"end":1471},"obj":"Phenotype"},{"id":"T177","span":{"begin":1548,"end":1551},"obj":"Phenotype"},{"id":"T178","span":{"begin":1654,"end":1669},"obj":"Phenotype"},{"id":"T179","span":{"begin":1785,"end":1807},"obj":"Phenotype"},{"id":"T180","span":{"begin":1809,"end":1828},"obj":"Phenotype"},{"id":"T181","span":{"begin":1830,"end":1841},"obj":"Phenotype"},{"id":"T182","span":{"begin":1847,"end":1856},"obj":"Phenotype"}],"attributes":[{"id":"A172","pred":"hp_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A173","pred":"hp_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/HP_0012592"},{"id":"A174","pred":"hp_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A175","pred":"hp_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A176","pred":"hp_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A177","pred":"hp_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A178","pred":"hp_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/HP_0000112"},{"id":"A179","pred":"hp_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A180","pred":"hp_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A181","pred":"hp_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/HP_0000093"},{"id":"A182","pred":"hp_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/HP_0000790"}],"text":"According to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

2_test

{"project":"2_test","denotations":[{"id":"32450165-32247631-66451083","span":{"begin":1585,"end":1588},"obj":"32247631"}],"text":"According to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

PMC:7243768 / 34415-36272 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:7243768 / 34415-36272 JSON TXT